Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Wei‐Pang Chung"'
Autor:
Wen-Der Lin, Chia-Hao Chang, Jhih-Kai Pan, Forn-Chia Lin, Yu-Chia Chen, Ya-Jyun Chen, Po-Shun Wang, Wei-Qiao Hong, Sheng-Yuan Chen, Cheng-Han Lin, Yao-Lung Kuo, Wei-Pang Chung, Hui-Chuan Cheng, Michael Hsiao, Chia-Ning Yang, Pei-Jung Lu
Publikováno v:
Cell Death and Disease, Vol 15, Iss 5, Pp 1-15 (2024)
Abstract Breast cancer (BC) is the most common cancer and the leading cause of cancer-related deaths in women worldwide. The 5-year survival rate is over 90% in BC patients, but once BC cells metastasis into distal organs, it is dramatically decreasi
Externí odkaz:
https://doaj.org/article/0e72ccd055a6489e86d1063eb6f30659
Autor:
Wan-Ju Annabelle Lee, Wei-Pang Chung, Shih-Chieh Shao, Edward Chia-Cheng Lai, Yi-Chen Chen, Chung-Han Ho
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Anti−vascular endothelial growth factors (VEGFs) treatment has been associated with an increased risk of thromboembolic events. Therefore, the use of anti−VEGFs for patients with colorectal cancers (CRC) has raised concerns ab
Externí odkaz:
https://doaj.org/article/6d7b6ce03a3e40dab4c70b1014eca123
Autor:
Pei-An Fu, Chin-Yao Shen, Shuen‑Ru Yang, Chun-Hui Lee, Hui-Wen Chen, Edward Chia-Cheng Lai, Wei-Pang Chung
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Denosumab, an inhibitor of receptor activator of nuclear factor kappa-B ligand, reduces skeletal-related events (SREs) and is approved for solid tumors with bone metastases. We studied long-term denosumab efficacy and safety because real-wor
Externí odkaz:
https://doaj.org/article/02fe4642992d4c29af5e341e538fa124
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 1, Pp 319-328 (2022)
Purpose: Evidence for optimizing the first-line chemotherapy for patients with metastatic triple-negative breast cancer (mTNBC) is lacking. This study assessed the utilization patterns of chemotherapy and associated survival outcomes in de novo mTNBC
Externí odkaz:
https://doaj.org/article/0cba5679d36c4cb8aa658a5283191ef5
Autor:
Wei-Pang Chung, Wei-Lun Huang, Wei-An Liao, Chun-Hua Hung, Chi-Wu Chiang, Chun Hei Antonio Cheung, Wu-Chou Su
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-14 (2022)
Abstract The prognosis of patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer has considerably improved. However, no reliable treatment besides anti-HER2 strategies has been available. FTY720, a small-molecule compoun
Externí odkaz:
https://doaj.org/article/18406677c8774ebb908ed3a933758328
Autor:
Wei-Pang Chung, Chun-Ting Yang, Shuen-Ru Yang, Ching-Yen Su, Hsin-Wei Su, Shang-Yun Liu, Huang-Tz Ou
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
BackgroundNeoadjuvant therapy, which aims to achieve a pathological complete response (pCR) for better overall survival (OS) has several advantages for patients with early breast cancer (eBC) and subtypes of HER2-positive (HER2+) and triple-negative
Externí odkaz:
https://doaj.org/article/0e26c5b9c6d840ba9753456c361399d2
Autor:
Zhu-Jun Loh, Kuo-Ting Lee, Ya-Ping Chen, Yao-Lung Kuo, Wei-Pang Chung, Ya-Ting Hsu, Chien-Chang Huang, Hui-Ping Hsu
Publikováno v:
World Journal of Surgical Oncology, Vol 19, Iss 1, Pp 1-10 (2021)
Abstract Background Sentinel lymph node biopsy (SLNB) is the standard approach for the axillary region in early breast cancer patients with clinically negative nodes. The present study investigated patients with false-negative sentinel nodes in intra
Externí odkaz:
https://doaj.org/article/2c630ce166304c58bc3c0bf4db99d1ed
Publikováno v:
Cancer Medicine, Vol 10, Iss 7, Pp 2370-2379 (2021)
Abstract Background Patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer who fail to respond to anti‐HER2 treatments have poor prognoses. Most trastuzumab‐resistant breast cancer cell lines available from biobank
Externí odkaz:
https://doaj.org/article/2ad19372c0e545b4b962000d8215c5d4
Autor:
Zhu-Jun Loh, Kuo-Ting Lee, Wei-Pang Chung, Wen-Chung Chen, Hsueh-Li Kuo, Po-Jun Chen, Hsi-Huei Lu, Hui-Ping Hsu
Publikováno v:
Formosan Journal of Surgery, Vol 50, Iss 2, Pp 69-73 (2017)
Secondary colon malignancy is rare and has a nonspecific presentation. Breast cancer is the second most common malignancy that metastasizes to the gastrointestinal (GI) tract. Here, we present the case of a 54-year-old woman diagnosed with breast can
Externí odkaz:
https://doaj.org/article/b1d131a77e12454ba7ce9a5c761d19b3
Autor:
Sara A Hurvitz, Roberto Hegg, Wei-Pang Chung, Seock-Ah Im, William Jacot, Vinod Ganju, Joanne Wing Yan Chiu, Binghe Xu, Erika Hamilton, Srinivasan Madhusudan, Hiroji Iwata, Sevilay Altintas, Jan-Willem Henning, Giuseppe Curigliano, José Manuel Perez-Garcia, Sung-Bae Kim, Vanessa Petry, Chiun-Sheng Huang, Wei Li, Jean-Sebastien Frenel, Silvia Antolin, Winnie Yeo, Giampaolo Bianchini, Sherene Loi, Junji Tsurutani, Anton Egorov, Yali Liu, Jillian Cathcart, Shahid Ashfaque, Javier Cortés
Publikováno v:
The lancet : international edition
Background An improvement in progression-free survival was shown with trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer in the progression-free survival interim analysis of the DESTINY-Breast0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f34ca39bb4e6f5a2f1a4d78197528f6d
https://doi.org/10.1016/s0140-6736(22)02420-5
https://doi.org/10.1016/s0140-6736(22)02420-5